Investigate / reported ownership
A
Agilent Technologies Inc
3 tracked reported owners · snapshot updated 2026-10-04. Delayed disclosures, not live holdings or an investment recommendation.
Who reports owning A?
Select a manager to inspect their portfolio. Reports may cover different quarters; portfolio weights describe disclosed long 13F holdings, not total economic exposure.
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Joel Greenblatt | 0.1% | 40q | $146M | 1,101,501 |
| 2 | William Von Mueffling | 2.5% | 40q | $17M | 126,437 |
| 3 | Greenhaven Associates | <0.1% | 40q | $1M | 10,700 |
Go beyond ownership.
Agilent sells instruments, software, services and consumables that laboratories use across their workflows, so customers pay for both analytical equipment and the supplies and services that support it.
Question to investigate: Can Agilent's broad laboratory portfolio and recent pathology acquisition perform if customer spending softens and costs remain relatively fixed?
Company research reviewed 2026-10-02; a dated source-linked starting point, not the investors’ stated reasons.
Understand the business and investment case →Filing dates and original SEC sources
Reported position changes
Net disclosed share changes—not individual trades or execution dates. NEW has no prior-position percentage comparison; EXIT weight refers to the previous report.
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| William Von Mueffling | TRIM | 2.5% | -95% | $17M | Jul 29, 2026 |
Keep your next step small.
Save the company and inspect its evidence. Recording a private view is optional and requires a separate, explicit save.
Record my own view →Optional email follow
Latticework Follow
Follow A
Email me only when a reviewed weekly edition contains a material new decision about A: a new position, exit, or a large share-count change that also clears the size threshold. There may be quiet weeks.
Confirm by email. Manage or stop follows in one click. See our privacy notice.
Long US 13F disclosures omit shorts and can be amended. CUSIP 00846U101. No current price, valuation or manager motive is inferred.